• 제목/요약/키워드: DNA mutation

검색결과 614건 처리시간 0.028초

가족집적성을 보이는 B형간염 바이러스 만성보유자에서 바이러스 유전자의 돌연변이와 주조직접합체 양상 - 질병발현 형태와의 관련성을 중심으로 - (Hepatitis B Virus DNA Mutation, Pattern of Major Histocompatibility Class-I among Familial Clustered HBV Carriers in Relation to Disease Progression)

  • 정승필;이효석;김정룡;안윤옥
    • Journal of Preventive Medicine and Public Health
    • /
    • 제33권3호
    • /
    • pp.323-333
    • /
    • 2000
  • Objectives : Chronic HBsAg carriers are the principal source of infection for other susceptible people, and are themselves at high risk of developing serious liver diseases. In Korea, it has been estimated that 65-75% of the HBsAg positives remained as persistent carriers. Additionally, familial clustering of MBV infection has frequently been observed among carriers. Some would become progressive, chronic hepatitis patients, and others would not. The aim of this study was to evaluate the association between various factors, such as the duration of infection, type of virus, mutation of precore/core region in HBV, major histocompatibility class-I, and developing chronic liver diseases among familial HBV carriers. Methods : Chronic carrier status was identified by repeated serological tests for HBsAg at intervals of six months or more. A familial chronic carrier was defined when the disease was observed in a family member over two generations. Two families were recruited, among which a total of 20 chronic HBsAg carriers(11 carriers in No.1, and 9 in No.2 family) were identified. Data on the general characteristics and liver disease status were collected. Identification of the HBV-DNA was successful only for 13 subjects among the 20 carriers. Analysis of viral DNA in terms of subtype, pre-core and core region mutations was carried out. The type of major histocompatibility class-1 for the 13 subjects was also analysed. Results & Conclusions : Seven of 10 chronic HBV carriers of the 1st generation and one of 10 of the 2nd generation were clinical patients with chronic hepatitis, the others, three of the 1 st and nine of the 2nd generation, were asymptomatic carriers. This data indicates that the duration of HBV carriage is one of the major factors for disease severity. The subtype of HBsAg analysed using MBV-DNA identified in 13 carriers were adr, and the pattern of precore nonsense mutation in HBV-DNA was identical among family members, which meads that the same virus strains were transmitted between the family members. The association between the precore or core mutations in HBV-DNA and the disease severity was not observed. While it was suggested that a specific type of MHC class-I may be related to disease progression.

  • PDF

DNA 데이터 저장을 위한 DNA 정보 은닉 기법 (DNA Information Hiding Method for DNA Data Storage)

  • 이석환;권기룡
    • 전자공학회논문지
    • /
    • 제51권10호
    • /
    • pp.118-127
    • /
    • 2014
  • DNA 데이터 저장(Data storage)은 DNA의 염기 서열에 대용량의 디지털 데이터를 저장하는 방법으로, 차세대 정보 저장 매개물로 인식되고 있다. 본 논문에서는 DNA 스테가노그라픽 기반으로 비부호 DNA 서열(Noncoding DNA sequence)에 정보를 저장하는 방법을 제안한다. 제안한 방법은 암호화된 데이터들을 정수 변화표에 의하여 데이터 염기 서열로 변환한 후, 시드 정보, 및 섹터 길이로 구성된 은닉 키에 의하여 비부호 염기 서열에 은닉한다. 따라서 단백질의 유전 기능이 유지되고, 원 DNA 서열없이 정보가 검출되며, 변이에 의하여 발생되는 오류가 검출된다. 기존 방법과의 비교 실험을 통하여 제안한 방법이 높은 bpn를 가지는 저장 효율을 가지며, 패리티 염기에 의하여 은닉된 정보의 오류 위치를 검출할 수 있음을 확인하였다.

A Case Report of HBsAg Seroclearance in Chronic Hepatitis B Patient

  • 이혁재
    • 대한임상검사과학회지
    • /
    • 제44권3호
    • /
    • pp.142-146
    • /
    • 2012
  • Hepatitis B surface antigen (HBsAg) seroclearance is a rare event in chronic hepatitis B virus (HBV) infection which acquires the disease early in life. A case study have examined with asymptomatic chronic hepatitis B carrier who exhibits HBsAg seroclearance in anti-HBe positive. We comprehensively studied the biochemical, virological and clinical aspects of a patient with HBsAg seroclearance. Liver biochemistry, serological markers, serum HBV DNA levels, and development of clinical complications were monitored. Mutation of hepatitis B virus is suspected serum HBsAg detected by the HBsAg assay systems of VITROS (OrthoClinical Diagnostics, USA), AxSYM (Abbott Laboratories, USA), Elecsys (Roche Diagnostics, Germany) and ADVIA Centaur (Bayer Diagnostics, USA). These four immunoassays showed negative results. Also, the patient had undetectable serum HBV DNA. Therefore, no mutation within the "a" determinant of HBsAg, which might escape detection from HBsAg immunoassay were found. Natural seroclearance was confirmed.

  • PDF

Genetic Diversity Estimation of the Rice Mutant Lines Induced by Sodium Azide

  • Shin, Young-Seop;Jeung, Ji-Ung
    • 한국육종학회지
    • /
    • 제43권1호
    • /
    • pp.23-31
    • /
    • 2011
  • To investigate dose-effect of a chemical mutagen, sodium azide on a rice elite line, Suweon472, seed aliquots were treated with five different concentrations of sodium azide. The degree of mutation levels of each aizde concentration were estimated by using DNA fingerprinting techniques such as RAPD and AFLP. Some selected mutant lines ($M_4$) were also subjected for DNA fingerprinting to estimate their mutation levels by comparing the banding patterns of the wild type, Suweon 472. RAPD and AFLP fingerprinting patterns indicated that dose-effect of different azide concentrations was not clear. With allele description of detected AFLPs among favorable mutant lines, it was possible to discriminate each mutant line from others which have similar phenotypes and reactions against pathogens. AFLP fingerprinting patterns of waxy mutant lines, otherwise, were highly homogeneous as well as their phenotypic and agronomic characters.

Identification of DNA Variations Using AFLP and SSR Markers in Soybean Somaclonal Variants

  • Lee, Suk-Ha;Jung, Hyun-Soo;Kyujung Van;Kim, Moon-Young
    • 한국작물학회지
    • /
    • 제49권1호
    • /
    • pp.69-72
    • /
    • 2004
  • Somaclonal variation, defined as phenotypic and genetic variations among regenerated plants from a parental plant, could be caused by changes in chromosome structure, single gene mutation, cytoplasm genetic mutation, insertion of transposable elements, and DNA methylation during plant regeneration. The objective of this study was to evaluate DNA variations among somaclonal variants from the cotyledonary node culture in soybean. A total of 61 soybean somaclones including seven $\textrm{R}_1$ lines and seven $\textrm{R}_2$ lines from Iksannamulkong as well as 27 $\textrm{R}_1$ lines and 20 $\textrm{R}_2$ lines from Jinju 1 were regenerated by organogenesis from the soybean cotyledonary node culture system. Field evaluation revealed no phenotypic difference in major agronomic traits between somaclonal variants and their wild types. AFLP and SSR analyses were performed to detect variations at the DNA level among somaclonal variants of two varieties. Based on AFLP analysis using 36 primer sets, 17 of 892 bands were polymorphic between Iksannamulkong and its somaclonal variants and 11 of 887 bands were polymorphic between Jinju 1 and its somaclonal variants, indicating the presence of DNA sequence change during plant regeneration. Using 36 SSR markers, two polymorphic SSR markers were detected between Iksannamulkong and its somaclonal variants. Sequence comparison amplified with the primers flanking Satt545 showed four additional stretches of ATT repeat in the variant. This suggests that variation at the DNA level between somaclonal variants and their wild types could provide basis for inducing mutation via plant regeneration and broadening crop genetic diversity.

gyrA and gyrB Mutations in Quinolone-resistant Strains of Enterobacteriaceae Isolated from General Hospitals in Busan

  • Kim, Yun-Tae;Kim, Tae-Un
    • 대한의생명과학회지
    • /
    • 제13권2호
    • /
    • pp.141-148
    • /
    • 2007
  • We determined the sequences of the quinolone resistance-determining region (QRDR) of gyrA and gyrB for 21 clinical strains of Enterobacteriaceae resistant to ciprofloxacin, norfloxacin and levofloxacin. The clinical strains were isolated from the specimens of three general hospitals in Busan. In the present study, we found mutations in type II topoisomerase (DNA gyrase) genes for all strains. We confirmed that some genera of Enterobacteriaceae of clinical specimen exhibited decreased sensitivity to fluroquinolone due to changes in Ser-83$\rightarrow$Leu and Asp-87$\rightarrow$Asn types on gyrA and alterations in Glu-465$\rightarrow$Arg and Ser-492$\rightarrow$Asn type on gyrB. All the twenty-one strains had a missense mutation in gyrA (codon 83 and 87). Three of them had an additional mutation in gyrB (codon 465 or 492), but one of them had an additional mutation in gyrB (codon 426, 427, 491, 495 and 496). The strains which had two mutations in type II topoisomerase genes (gyrA and gyrB) were significantly more resistant to fluoroquinolones than those with a single mutation in gyrA (mean MICs of ciprofloxacin: $\geq8\mu$g/ml, mean MICs of levofloxacin: $\geq16\mu$g/ml). Interestingly, the examination of silent nucleotide changes n the gyrA and gyrB genes revealed six different patterns of DNA polymorphism, respectively. Fifteen strains of the twenty-one strains bearing the gyrase A mutation shared the same polymorphism and eleven strains of the twenty-one strains bearing the gyrase B mutation shared the same polymorphism.

  • PDF

BRAF Mutations in Iranian Patients with Papillary Thyroid Carcinoma

  • Ranjbari, Nastran;Almasi, Sara;Mohammadi-asl, Javad;Rahim, Fakher
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권4호
    • /
    • pp.2521-2523
    • /
    • 2013
  • Background: Papillary thyroid cancer or papillary thyroid carcinoma (PTC) is the most common thyroid cancer. The fact that it occasionally occurs in women aged 30-40 years old suggests that genetic alterations are involved its genesis. Recently, activator mutations in BRAF gene have been relatively frequently discovered. Materials and Methods: In this study, we tested 63 DNA samples from PTC patients to identify the V600E mutation frequency in the Ahvaz population. DNA was isolated from formalin fixed paraffin-embedded (FFPE) PTC tumor tissues. Genotyping was performed by PCR-RFLP and confirmed by direct DNA sequencing of a subset of PCR products. PCR-RFLP data were reported as genotype frequencies and percentages. Results: Forty nine out of 63 patients (77.8%) had a mutated heterozygote form while 14 (22.2%) showed normal genotype but none demonstrated a mutant homozygote genotype. The frequency of V600E mutation was significantly high in PTC patients. Conclusions: These findings support involvement of V600E mutations in PTC occurrence in Iran. Assessment of correlations between BRAF V600E mutations and papillary thyroid cancer progression needs to be performed.

DNA 코딩과 진화연산을 이용한 함수의 최적점 탐색방법 (Global Optimum Searching Technique Using DNA Coding and Evolutionary Computing)

  • 백동화;강환일;김갑일;한승수
    • 한국지능시스템학회논문지
    • /
    • 제11권6호
    • /
    • pp.538-542
    • /
    • 2001
  • DNA computing 은 Adleman 실험 이후에 많은 여러 가지 최적화 문제에 적용되어 왔다. DNA computing의 장점은 스트링의 길이가 가변적이고 4가지 염기를 이용하기 때문에 복잡한 문제에 전역 최적점을 찾는데 기존의 다른 방법보다는 효율적이라는것이다. 본 논문에서는 이진 스트링의 개체 지단 위에서 모의진화를 일으켜 효율적으로 최적 해를 탐색하는 GA(Genetic Algorithms)와 생체 분자와 DNA를 계산의 도구 및 정보 저장도구로 사용하여 A(Adenine). C(Cytosine), G(Guanine), T(Thymine)등의 4가지 염기를 사용하는 DNA 코딩방법을 이용하여multi-modal 함수의 전역 최적점을 탐색하는 문제에서의 각각의 성능을 조사하였다. Selection, crossover, mutation등의 GA연산자를 DNA를 코딩에 동일하게 적용하였으며 최적의 해를 탐색하는데 걸리는 시간과 찾아낸 최적해의 값을 평가한다.을 평가한다.

  • PDF

살균제 carbendazim이 DNA, 유전자 및 염색체에 미치는 영향 (Effects of carbendazim on DNA, gene and chromosome)

  • 이제봉;성필남;정미혜;신진섭;강규영
    • 농약과학회지
    • /
    • 제8권4호
    • /
    • pp.288-298
    • /
    • 2004
  • 광범위 보호 살균제인 carbendazim이 DNA, 유전자 및 염색체에 미치는 영향을 평가하기 위하여 Ames가 개발한 미생물복귀돌연변원성시험, CHL (chinese hamster lung fibroblast cell) 세포를 이용한 염색체 이상시험, DNA 손상시험 및 마우스 골수세포를 이용한 소핵시험을 수행하였다. Carbendazim $156\sim2,500{\mu}g/plate$ 농도로 직접법 및 대사활성화법으로 TA 1535, TA 1537, TA 98 및 TA 100에서 수행한 Ames test결과 음성 대조군(DMSO)과 유사한 colony수를 보여 유전자의 염기절단에 의한 결손이나 염기 치환을 일으키지 않았다. 염색체에 미치는 영향을 검색하기 위하여 CHL세포에 $2.0\sim32.0{\mu}g/mL$의 농도로 carbendazim을 처리하여 염색체이상시험을 수행한 결과 염색분체 절단과 같은 구조이상은 없었으나 염색체의 수에 변화가 관찰되어 수적 이상은 인정되었다. Carbendazim 25, 50 및 $100{\mu}g/mL$을 마우스에 처리하여 30분, 60분 및 120분에 DNA에 직접 노출시켜 DNA손상 시험을 수행한 결과 60분까지는 영향이 없었으나, 120분 노출 군에서 대조군에 비해 $22\sim27%$정도의 DNA이동거리가 증가하여 약간의 손상이 관찰되었으며, 세포에 노출시켰을 때도 중 농도와 저 농도에서 16%의 이동거리 증가와 120분 노출시켰을 때 $10%\sim26%$의 이동거리 증가가 있어 DNA에 직접 노출한 경우와 비슷하였다. Carbendazim 375, 750 및 1,500 mg/kg 농도로 투여한 소핵시험결과 음성으로 판단되었으며, 골수세포에 대한 세포독성도 관찰되지 않았다. 이상의 결과에선 benzimidazole계 살균제 carbendazim이 DNA손상 및 염색체의 수적이상을 일으킨다는 것을 알 수 있었다. 이와 같은 결과는 계속적으로 논란이 되고 있는 benzimidazole계 농약인 benomyl이나 carbendazim에 장기적으로 인체에 노출되었을 경우 유전물질에 영향을 미칠 수 있을 것으로 생각되나 만성독성성적과 노출량 등 구체적인 자료를 이용한 위해성평가를 수행하여야 보다 정확한 판단을 할 수 있을 것으로 사료되었다.

A compound heterozygous mutation in the FMO3 gene: the first pediatric case causes fish odor syndrome in Korea

  • Kim, Ji Hyun;Cho, Sung Min;Chae, Jong-Hee
    • Clinical and Experimental Pediatrics
    • /
    • 제60권3호
    • /
    • pp.94-97
    • /
    • 2017
  • Trimethylaminuria (TMAuria), known as "fish odor syndrome," is a congenital metabolic disorder characterized by an odor resembling that of rotting fish. This odor is caused by the secretion of trimethylamine (TMA) in the breath, sweat, and body secretions and the excretion of TMA along with urine. TMAuria is an autosomal recessive disorder caused by mutations in flavin-containing monooxygenase 3 (FMO3). Most TMAuria cases are caused by missense mutations, but nonsense mutations have also been reported in these cases. Here, we describe the identification of a novel FMO3 gene mutation in a patient with TMAuria and her family. A 3-year-old girl presented with a strong corporal odor after ingesting fish. Genomic DNA sequence analysis revealed that she had compound heterozygous FMO3 mutations; One mutation was the missense mutation p.Val158Ile in exon 3, and the other was a novel nonsense mutation, p.Ser364X, in exon 7 of the FMO3 gene. Familial genetic analyses showed that the p.Val158Ile mutation was derived from the same allele in the father, and the p.Ser364X mutation was derived from the mother. This is the first description of the p.Ser364X mutation, and the first report of a Korean patient with TMAuria caused by novel compound heterozygous mutations.